Literature DB >> 12562286

Sclerosing adenosis of the prostate. Histologic features in needle biopsy specimens.

Rafael J Luque1, Antonio Lopez-Beltran, Carlos Perez-Seoane, Sueli Suzigan.   

Abstract

Sclerosing adenosis of the prostate is a pseudoneoplastic lesion that can mimic prostate cancer. Because the lesion is more common in the transition zone, which is only rarely sampled in needle biopsy, it is uncommon to see examples of this lesion in biopsy specimens. Because sampling of the transition zone of the prostate is likely to become more frequent, practicing surgical pathologists must be aware of the morphologic features of sclerosing adenosis of the prostate in needle biopsy specimens, in order to avoid misinterpretation of sclerosing adenosis of the prostate, a benign lesion, as prostate adenocarcinoma. We report the morphologic findings of sclerosing adenosis of the prostate in 3 needle biopsy specimens from 2 patients diagnosed as having sclerosing adenosis. We found a combination of histologic (mainly a cellular myxoid stroma and a double-cell population of acinar cells) and immunohistochemical features demonstrating a continuous basal cell layer with myoepithelial differentiation to be diagnostic.

Entities:  

Mesh:

Year:  2003        PMID: 12562286     DOI: 10.5858/2003-127-e14-SAOT

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  2 in total

1.  Hybrid sclerosing adenosis and basal cell hyperplasia of the prostate.

Authors:  Naoto Kuroda; Kazunobu Katto; Yuji Ohtsuki; Ondrej Hes; Michal Michal; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

2.  Prostate sclerosing adenopathy: A clinicopathological and immunohistochemical study of twelve patients.

Authors:  Run-Lin Feng; Yan-Ping Tao; Zhi-Yong Tan; Shi Fu; Hai-Feng Wang
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.